Member Info for Tornadotony

Far more positive heading.

I am still holding my HZM no intention of selling it.

Two of them were mine this morning as buys at 8.62. Average downs in two different accounts. Starting to sort out a mess in Shanta.

These items were part of the June placing work programme.

1. The applications to the Department of Environment concerning Saltend were to be submitted this month. This was emphasised in the September Webinar. Environmental approvals to enable the start of construction are extremely important. Submitting the actual application is vital as the clock then ticks on the civil service side. I have written to the company about the issue and they informed that the staff member responsible is being chased up on this.

2. The COOLA results were also part of the June placing to cover Australian laboratory costs. These were delayed initially by Covid-19. However, they were expected by this month as the very latest. These results are critical to help with financing as LJ feedstock was only resourced for 14 years too Saltend. Addition of COOLA adds to the viability of financing. This again is a critical issue as en extension to 20 years of supply from 14 helps in financial modelling. I have also written to the company on this matter and again its being looked into.

An RNS on both of these issues has a big impact on Pensana share price. They remove two critical road blocks on the financing of this project. What this company can not do is have placings against work programmes, say repeatably they will be delivered and then not do appear to do the work at all. The questions that I raise with this company are all part of due diligence that anyone providing them with funds would make and ask of them.

Fair enough and I am sure hope admissions are observational.

NHS has taken in 34 under 5 year olds as hospital admissions as of yesterday. Significant numbers of nursery age children testing omicron positive. Sadly a lot more admissions in the 5 and under age group may be expected in paediatric and other hospitals. The myth of omicron being mild may soon evaporate. Spain and Germany now considering vaccinating very young children.

I sense Sprott Money may have got this right. Centamin to go back up to 112p area mid to late first quarter. What was missing from all of the FED talk was climate protection and implementing COP26 measures. The reason being is that they are inflationary. Doing nothing is unproductive GDP and negative growth.

5 hourly RSI now on 12 and the daily on 24. Polymetal 5 hourly is on 21 RSI read out. I will check and see if other indicators are setting bombed out oversold records.

3bear the additional volume over normal activity is well under 2% over the past two weeks or so. Not a huge amount of evidence of institutional selling thus far.

This morning I was in our local bank and hearing that it was the quiet Christmas run up and that activity 10 days before Christmas was nothing like what they have seen before. A number of local businesses that rely on public facing customers are closing for good. Omicron on some cases has taken away last hopes of a recovery. At the same time inflation is just taking off further and with interest rates possibly going up as well, growth is going to plummet. The word on the street is the pound is going to take a big hit. I can see people emptying bank accounts at some point and put their money into bombed out stocks such as Centamin.

The toolkit of therapies needed to manage Covid-19 infections is likely to contain a number of useful medications. Clinicians will have protocols as to when they should use them during the course of infection and where they have a material outcome of benefit to particular patients with ascribed symptoms. Synairgen is focusing on patients that are generally in need of hospitalisation or have arrived in the hospital setting and are breathless and requiring oxygen therapy support. So medications taken at earlier stages do not compete with the Synairgen cohort likely to be arriving at hospital. The hospitalisation cohort per day is currently around 1250 people in England which may have 40,000 known run rate of positive results. Adding the unknown tested per day to that 40,000 gives a population cohort size of a fraction of a percent, however it has an accumulative impact over time. The therapies tackling this cohort using passive therapy techniques such as Adagio monoclonal antibodies which again is injected into the blood stream (as opposed to Synairgen's immunomodulator that interactions with chemical receptors in surface lung tissue through a nebuliser), usually delivers worse outcomes for those patients requiring high flow oxygen therapy. A number of studies have shown the deficiencies of the different injected monoclonals that do not bind with receptors in the lung that impact on viral replication within that organ. Monoclonals antibody therapies have a place in the toolkit which is to aid the provision of immunity for those that are non-responders to vaccine therapies, waning immunity from previous vaccinations or may have been immunocompromised by other treatments for other diseases. Like Synairgen they will have their own best fitting cohort with their own therapy market value. It would be quite extraordinary for one single drug to replace all the others in the toolkit. Covid-19 is a complex mutating virus and hence the value of a variety of products with different intervention applications.

I came out of AAZ on a profit and reluctantly out of Rainbow Rare also on profits to add on Centamin today as an average down. On those I came out of I would be down with no profits at all if I stayed in, so I am hoping it turns out okay. Centamin price is dependent on what happens to gold. I calculated if on that Sprott interview assessment of $2100 gold area arises then Centamin would recover to 112p area by March 2022. I would be hugely happy if that scenario arose. I would be ecstatic if it went higher.

https://www.thetechnicaltraders.com/2022-precious-metals-forecast-video/ Courtesy of Svend on Polymetal board.

I checked what was said about the pennant formation on momthly charts which is also true on weekly charts. This coincides to a major break in gold in Q1 2022. At the very least it gives us hope in the darkest hours.

Omicron is concerning the FED. Likely to stay with the usual taper and see how it goes. Whatever the FED does it won't change the inflation outlook as more companies re-shore to USA production from the far east. Adding to company costs further with interest rate hikes actually makes the inflation worse and goes against COP26 initiatives. USA will also need more people to work in manufacturing and wages in that sector likely to go up and they usually vote democrat.

Its so bombed out that I can not recall it being this low.

Submission of Environmental permit applications for Saltend is now do. Angola mining work prior to its application was still on-going but needs an update to us. COOLA resource results are also now do. Both these items were paid for in June placing. They were promised as being the latest for this month in December. Both items not mentioned for 2022 in AGM presentation. Both items are significant for the company and both items impact hugely on any financial or funding decisions being made. These issues get the company to its next target on deliverables. We should also have more detail on the FEED and not just a one page outline.

As much as some of us would like to review 120 work packages, I known most would regard as to much info, but a spread sheet of the actual list would be helpful in seeing how the projects are developing. We also need an updated risk assessment sheet.

Apologies for previous heading I will get deleted.

The latest trader views on Bloomberg is that UK interest rates not moving up in December or January. Pound set to devalue against USD (129-130) and Euro (86-87) by around 2%. A small tailwind for Centamin on the cards. UK economy is slowing down, growth is falling and interest rates would just accelerate a slow down. Brexit has hit UK trade.

Same here halfpenny.

Its a waiting game. In the UK with so much money in the banks not earning anything, a lot of people will start buying gold as an inflation hedge. The issue about inflation goes well beyond what happens in 2022. Its like central bankers having amnesia in that COP26 never happened and no effort will be made towards climate protection activity. In addition the central banks are actively subsidising carbon producing industries and actively penalising the climate protection equity companies with 12-16% interest rates. This has gone on all year and on top of this central banks and governments are quite happy for cryptocurrencies to carry out with their excessive energy use that dwarfs the entire precious metals sector which is trying to use more renewable energy sources. The climate change agenda is inflationary and what central bankers and politicians can not get into their heads is that there is a huge cost to repair all the damage from climate extreme events and this is not constructive GDP and its not productive either and it has a greater inflationary impact down the line. Whatever happens, inflation is not go to stay at 2% unless the intention is to stay on the high carbon dioxide producing path we are on. Tony

The support line on the daily chart held and the back testing appears to have completed. The rising support line arrives at 200p around 12 January 2022 on its current path. The top of the current trading range is 248p.

Can anyone find out from their good source that someone at Synairgen is looking into the possibility of a dose regime for the Synairgen Covid-19 therapy for children under 5 being hospitalised because of omicron. This could become urgent in the UK in mid-winter and helpful to know if someone is keeping an eye on developments. Perhaps MHRA need to be prepared as well.